Myasthenia gravis: open trials in Serbia

• NCT06463587

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  University Clinical Center of Serbia - Clinic of Neurology, Belgrade · University Clinical Center Kragujevac - Department of Neurology, Kragujevac · University Clinical Center Nis - Parent, Niš · Clinical Center of Vojvodina - Department of Neurology, Novi Sad

  Registry updated 2026-10-21

• NCT06414954

  Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

  Trial Treatment · Phase 2 · NMD Pharma A/S

  University Clinical Center of Serbia, Neurology Clinic, Belgrade · University Clinical Center Nis, Neurology Clinic, Niš

  Registry updated 2026-08-21

• NCT07039916

  Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Immunovant Sciences GmbH

  Belgrade · Niš

  Registry updated 2026-07-30

• NCT07250750

  A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

  Trial Treatment · Phase 1/2 · ImmunAbs Inc.

  General Hospital MSB Medical System Belgrade, Belgrade

  Registry updated 2026-02-11

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error